Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 8 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 29, 2019 Filed Oct 31, 2019 22:03 UTC |
5AM Ventures V, L.P.10% owner
5AM Partners V, LLC10% owner
5AM Opportunities I, L.P.10% owner
5AM Opportunities I (GP), LLC10% owner
PARMAR KUSH10% owner
ROCKLAGE SCOTT M10% owner
Schwab Andrew J.10% owner
|
ConversionSeries A Preferred Stock · Derivative | 3,146,551 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-19-058504 · a4.xml · derivative · entry 3 5AM Ventures V, L.P. · CIK 0001674324 · 10% owner 5AM Partners V, LLC · CIK 0001791889 · 10% owner 5AM Opportunities I, L.P. · CIK 0001753000 · 10% owner 5AM Opportunities I (GP), LLC · CIK 0001790778 · 10% owner PARMAR KUSH · CIK 0001664281 · 10% owner ROCKLAGE SCOTT M · CIK 0001219014 · 10% owner Schwab Andrew J. · CIK 0001598549 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 Underlying: Common Stock · 2,097,700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These shares of Series A Preferred Stock and Series B Preferred Stock (collectively, "Preferred Stock") automatically converted into shares of the Issuer's Voting Common Stock ("Common Stock"), on a 1-for-1.5 basis, immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · price: These shares of Series A Preferred Stock and Series B Preferred Stock (collectively, "Preferred Stock") automatically converted into shares of the Issuer's Voting Common Stock ("Common Stock"), on a 1-for-1.5 basis, immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: These shares of Series A Preferred Stock and Series B Preferred Stock (collectively, "Preferred Stock") automatically converted into shares of the Issuer's Voting Common Stock ("Common Stock"), on a 1-for-1.5 basis, immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: These shares of Series A Preferred Stock and Series B Preferred Stock (collectively, "Preferred Stock") automatically converted into shares of the Issuer's Voting Common Stock ("Common Stock"), on a 1-for-1.5 basis, immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F2 · ownership.direct: Shares are held directly by 5AM Ventures V, L.P. ("5AM V"). F3 · ownership.direct: 5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Dr. Parmar, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Preferred Stock held directly by 5AM V, except to the extent of its or his pecuniary interest therein. F2 · ownership.nature: Shares are held directly by 5AM Ventures V, L.P. ("5AM V"). F3 · ownership.nature: 5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Dr. Parmar, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Preferred Stock held directly by 5AM V, except to the extent of its or his pecuniary interest therein. Read SEC document |
| October 29, 2019 Filed Oct 31, 2019 22:03 UTC |
5AM Ventures V, L.P.10% owner
5AM Partners V, LLC10% owner
5AM Opportunities I, L.P.10% owner
5AM Opportunities I (GP), LLC10% owner
PARMAR KUSH10% owner
ROCKLAGE SCOTT M10% owner
Schwab Andrew J.10% owner
|
PurchaseCommon Stock | 454,545 | $11.00 | $4,999,995.00 |
DisclosureSEC source: 0001104659-19-058504 · a4.xml · nonDerivative · entry 2 5AM Ventures V, L.P. · CIK 0001674324 · 10% owner 5AM Partners V, LLC · CIK 0001791889 · 10% owner 5AM Opportunities I, L.P. · CIK 0001753000 · 10% owner 5AM Opportunities I (GP), LLC · CIK 0001790778 · 10% owner PARMAR KUSH · CIK 0001664281 · 10% owner ROCKLAGE SCOTT M · CIK 0001219014 · 10% owner Schwab Andrew J. · CIK 0001598549 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 454,545 F4 · ownership.direct: Shares are held directly by 5AM Opportunities I, L.P. ("Opportunities"). F5 · ownership.direct: 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Mr. Schwab and Dr. Parmar disclaims beneficial ownership of the shares of Common Stock held directly by Opportunities, except to the extent of its or his pecuniary interest therein. F4 · ownership.nature: Shares are held directly by 5AM Opportunities I, L.P. ("Opportunities"). F5 · ownership.nature: 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Mr. Schwab and Dr. Parmar disclaims beneficial ownership of the shares of Common Stock held directly by Opportunities, except to the extent of its or his pecuniary interest therein. Read SEC document |
| October 29, 2019 Filed Oct 31, 2019 22:03 UTC |
5AM Ventures V, L.P.10% owner
5AM Partners V, LLC10% owner
5AM Opportunities I, L.P.10% owner
5AM Opportunities I (GP), LLC10% owner
PARMAR KUSH10% owner
ROCKLAGE SCOTT M10% owner
Schwab Andrew J.10% owner
|
ConversionCommon Stock | 3,214,721 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-19-058504 · a4.xml · nonDerivative · entry 1 5AM Ventures V, L.P. · CIK 0001674324 · 10% owner 5AM Partners V, LLC · CIK 0001791889 · 10% owner 5AM Opportunities I, L.P. · CIK 0001753000 · 10% owner 5AM Opportunities I (GP), LLC · CIK 0001790778 · 10% owner PARMAR KUSH · CIK 0001664281 · 10% owner ROCKLAGE SCOTT M · CIK 0001219014 · 10% owner Schwab Andrew J. · CIK 0001598549 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 3,214,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These shares of Series A Preferred Stock and Series B Preferred Stock (collectively, "Preferred Stock") automatically converted into shares of the Issuer's Voting Common Stock ("Common Stock"), on a 1-for-1.5 basis, immediately prior to the completion of the Issuer's initial public offering for no additional consideration. The Preferred Stock had no expiration date. F2 · ownership.direct: Shares are held directly by 5AM Ventures V, L.P. ("5AM V"). F3 · ownership.direct: 5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Dr. Parmar, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Preferred Stock held directly by 5AM V, except to the extent of its or his pecuniary interest therein. F2 · ownership.nature: Shares are held directly by 5AM Ventures V, L.P. ("5AM V"). F3 · ownership.nature: 5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Dr. Parmar, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Preferred Stock held directly by 5AM V, except to the extent of its or his pecuniary interest therein. Read SEC document |
| October 24, 2019 Filed Oct 29, 2019 00:43 UTC |
Binder GwendolynEVP, Science & Technology
|
GrantStock Option (Right to Buy) · Derivative | 29,908 | $0.00 Strike: $11.00 | $0.00 |
DisclosureSEC source: 0000899243-19-026020 · doc4.xml · derivative · entry 1 Binder Gwendolyn · CIK 0001791742 · EVP, Science & Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,908 Underlying: Common Stock · 29,908 shares Expires 2029-10-23 F1 · derivative.exercise_date: This option vests over four years, with 25% vesting on October 24, 2020, and the remaining shares vesting in 12 equal quarterly installments thereafter. Read SEC document |
| October 24, 2019 Filed Oct 29, 2019 00:39 UTC |
Marda AnupChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 66,463 | $0.00 Strike: $11.00 | $0.00 |
DisclosureSEC source: 0000899243-19-026018 · doc4.xml · derivative · entry 1 Marda Anup · CIK 0001790410 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,463 Underlying: Common Stock · 66,463 shares Expires 2029-10-23 F1 · derivative.exercise_date: This option vests over four years, with 25% vesting on October 24, 2020, and the remaining shares vesting in 12 equal quarterly installments thereafter. Read SEC document |
| October 24, 2019 Filed Oct 29, 2019 00:38 UTC |
Nichtberger StevenDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 99,714 | $0.00 Strike: $11.00 | $0.00 |
DisclosureSEC source: 0000899243-19-026017 · doc4.xml · derivative · entry 1 Nichtberger Steven · CIK 0001487989 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,714 Underlying: Common Stock · 99,714 shares Expires 2029-10-23 F1 · derivative.exercise_date: This option vests over four years, with 25% vesting on October 24, 2020, and the remaining shares vesting in 12 equal quarterly installments thereafter. Read SEC document |
| October 24, 2019 Filed Oct 29, 2019 00:38 UTC |
Chang David J.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 48,836 | $0.00 Strike: $11.00 | $0.00 |
DisclosureSEC source: 0000899243-19-026016 · doc4.xml · derivative · entry 1 Chang David J. · CIK 0001790552 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,836 Underlying: Common Stock · 48,836 shares Expires 2029-10-23 F1 · derivative.exercise_date: This option vests over four years, with 25% vesting on October 24, 2020, and the remaining shares vesting in 12 equal quarterly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.